Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (171-180 of 450) with videos related to

Pageof 45
Sort By:
Annals of the New York Academy of Sciences|September 6, 2007
Identification by proteomic tool of atypical anti-liver/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantationStéphanie Huguet, Joelle Vinh, Catherine Johanet, et al.
Journal of Virology|April 29, 2005
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cellsAnne-Marie Roque-Afonso, Delphine Ducoulombier, Gaëtana Di Liberto, et al.
Antiviral Therapy|February 5, 2008
Viral and clinical factors associated with surface gene variants among hepatitis B virus carriersAnne Marie Roque-Afonso, Marie-Pierre Férey, Thoai Duong Ly, et al.
Transplantation|September 23, 2016
Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant RecipientsMarilyne Debette-Gratien, Jean-Baptiste Woillard, Nicolas Picard, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantationElina Teicher, Chadi Abbara, Jean-Charles Duclos-Vallée, et al.
Medecine Sciences : M/S|April 7, 2012
[HIP/PAP, a new drug for acute liver failure]Nicolas Moniaux, Marion Darnaud, Alexandre Dos Santos, et al.
The Analyst|January 13, 2015
Vibrational signatures to discriminate liver steatosis gradesChengyuan Peng, Franck Chiappini, Slávka Kaščáková, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2008
Chickenpox-associated fulminant hepatitis that led to liver transplantation in a 63-year-old womanAnne-Marie Roque-Afonso, Marie-Pierre Bralet, Philippe Ichai, et al.
Transplantation|December 4, 2013
Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur?Philippe Sultanik, Audrey Coilly, Mylène Sebagh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 9, 2010
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal diseaseMarkus Peck-Radosavljevic, John Boletis, Fatih Besisik, et al.
Pageof 45

Showing results (171-180 of 450) with videos related to

Sort By:
Pageof 45
Annals of the New York Academy of Sciences|September 6, 2007
Identification by proteomic tool of atypical anti-liver/kidney microsome autoantibodies targets in de novo autoimmune hepatitis after liver transplantationStéphanie Huguet, Joelle Vinh, Catherine Johanet, et al.
Journal of Virology|April 29, 2005
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cellsAnne-Marie Roque-Afonso, Delphine Ducoulombier, Gaëtana Di Liberto, et al.
Antiviral Therapy|February 5, 2008
Viral and clinical factors associated with surface gene variants among hepatitis B virus carriersAnne Marie Roque-Afonso, Marie-Pierre Férey, Thoai Duong Ly, et al.
Transplantation|September 23, 2016
Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant RecipientsMarilyne Debette-Gratien, Jean-Baptiste Woillard, Nicolas Picard, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 1, 2009
Enfuvirtide: a safe and effective antiretroviral agent for human immunodeficiency virus-infected patients shortly after liver transplantationElina Teicher, Chadi Abbara, Jean-Charles Duclos-Vallée, et al.
Medecine Sciences : M/S|April 7, 2012
[HIP/PAP, a new drug for acute liver failure]Nicolas Moniaux, Marion Darnaud, Alexandre Dos Santos, et al.
The Analyst|January 13, 2015
Vibrational signatures to discriminate liver steatosis gradesChengyuan Peng, Franck Chiappini, Slávka Kaščáková, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 30, 2008
Chickenpox-associated fulminant hepatitis that led to liver transplantation in a 63-year-old womanAnne-Marie Roque-Afonso, Marie-Pierre Bralet, Philippe Ichai, et al.
Transplantation|December 4, 2013
Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur?Philippe Sultanik, Audrey Coilly, Mylène Sebagh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 9, 2010
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal diseaseMarkus Peck-Radosavljevic, John Boletis, Fatih Besisik, et al.
Pageof 45